Moreover, measuring the basal autophagy level of patient tumors/tissues in ex vivo tumor models by using a combination of autophagy markers as SQSTM1/p62 and Atgs may help determine a patient’s response to PARPi56,57. The gene discussed is SQSTM1; the disease is neoplasm.